Clinical Trials Logo

Filter by:
NCT ID: NCT04490694 Enrolling by invitation - Clinical trials for Hepatocellular Carcinoma

TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma

Start date: March 1, 2020
Phase: Phase 2
Study type: Interventional

It is an exploratory clinical study aimed to evaluate the efficacy and safety of TACE combined with Lenvatinib in the treatment of patients with BCLC stage B and C HCC.Treatment will continue until the death or intolerable toxicity or patients withdrawal of consent,and the target sample size is 54 individuals.

NCT ID: NCT04483284 Enrolling by invitation - Clinical trials for Hepatocellular Carcinoma

Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients

Start date: June 24, 2020
Phase: Phase 2
Study type: Interventional

It is an exploratory clinical study aimed to evaluate the efficacy and safety of TACE combined with Camrelizumab in the treatment of patients with BCLC stage B and C HCC.Treatment will continue until disease progression or intolerable toxicity or patients withdrawal of consent,and the target sample size is 60 individuals.

NCT ID: NCT04470063 Enrolling by invitation - Clinical trials for Anemia Associated Chronic Kidney Disease

Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases.

Start date: November 17, 2020
Phase: Phase 1
Study type: Interventional

The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multi-dose DDO-3055 tablets in patients with anemia of non-dialysis chronic kidney diseases.

NCT ID: NCT04455191 Enrolling by invitation - Clinical trials for In Vitro Fertilization

Comparison of Thawing Embryos in Advance and on the Day of Transfer on Pregnancy Outcomes in FET Cycle

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Respectively for patients with repeated transplant failure and routine patients, Thawing frozen embryos in advance (18h) to extend the duration of embryonic development or thawing embryos on the day of transfer in the frozen embryo transfer cycle, to analyze which way can improve clinical pregnancy outcomes, is there a significant difference between the two ways or two types of patients?

NCT ID: NCT04454034 Enrolling by invitation - Clinical trials for Rheumatoid Arthritis of Ankle

Arthroscopic Synovectomy Combined With DMARDs in the Treatment of Refractory Elbow Rheumatoid Arthritis

Start date: August 1, 2019
Phase:
Study type: Observational

Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic and aggressive polyarthritis. The prevalence of RA in China is about 0.42%. Arthroscopic synovectomy (AS) is an important method to save the function of joint in the treatment of refractory RA. The clinical trial is to study the value of AS combine with DMARDs in the early stage of refractory RA.

NCT ID: NCT04443283 Enrolling by invitation - Infertility Clinical Trials

The Effect of Latent Tuberculosis Infection on the Pregnancy Outcome of IVF-ET

Start date: January 1, 2019
Phase:
Study type: Observational

This study evaluate the effect of latent infection of tuberculosis on the pregnancy outcome of IVF-ET in infertile patients with radiographic lesions suggesting old healed tuberculosis

NCT ID: NCT04436874 Enrolling by invitation - Clinical trials for Fecal Microbiota Transplantation

Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease

FMT-IBD
Start date: September 23, 2019
Phase: N/A
Study type: Interventional

Fecal microbiota transplantation (FMT), defined as infusion of feces from healthy donors to affected subjects, is a method to restore a balanced gut microbiota and has attracted great interest in recent years due to its efficacy and ease of use.

NCT ID: NCT04433143 Enrolling by invitation - Acne Vulgaris Clinical Trials

Evaluate the Efficacy and Safety of Intense Pulsed Light Filters Combined With Oral Medication in the Treatment of Acne

Start date: May 15, 2020
Phase: N/A
Study type: Interventional

1. Acne is a chronic inflammatory disease involving the hair follicles and sebaceous glands, characterized by acne, papules, pustules, nodules, and cysts. Acne often occurs in sebum overflow areas such as the face, chest, back and so on. It is a common skin lesion, which not only affects physical health, but also brings psychological disorders and psychosocial problems to patients. At present, the common treatment methods of acne include health education, topical drugs, oral drugs and medical cosmetic treatment. 2. Intense pulsed light has been widely accepted as a non-invasive and non-serious treatment for acne. The M22 strong light and laser system Acne filter has a wavelength of 400-600/800-1200nm. 3. Although there are many treatments for acne, the slow response and easy recurrence of acne are still common problems that trouble doctors and patients. We clinically use drugs combined with intense pulsed light treatment, and the efficacy of the patients is fair, but currently lack of clinical research data support. This study intends to evaluate the effectiveness of different methods in the treatment of moderate and severe acne by evaluating different bands of intense pulsed light combined with drugs, and to observe whether the treatment with oral tetracycline antibiotics combined with intense pulsed light is safe.

NCT ID: NCT04432701 Enrolling by invitation - Cough Clinical Trials

Extubation in Pediatric Patients: Proactive or Passive?

Start date: July 10, 2020
Phase: N/A
Study type: Interventional

Smooth extubation process can reduce the complications in recovery time. This study aimed to investigate what is the better time to extubation when children is breathing spontaneously and adequately: waiting until children have movements or wakefulness (passive extubation)or removing endotracheal tube directly (proactive tracheal extubation).

NCT ID: NCT04431180 Enrolling by invitation - Blood Donation Clinical Trials

Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#

Start date: June 13, 2020
Phase: N/A
Study type: Interventional

The fight against the spread of the 2019-nCoV epidemic has achieved some success in China, but the epidemic is far from over. A key factor making the epidemic under control in China is the government's call for social distance, which has led to few people going out for donation. As a result, the number of blood donors on the streets has been continuing to decline. The first urgent recruitment of blood donors had been implemented during the period from 30 April to 10 May via emergency recruitment SMS . This second repeat trial has been designed to further confirm the results from the the first recruitment by comparing which information extraction frameworks would be more sensitive to blood donors in emergency situations.